With the development of the disease of Polycystic Kidney Disease (PKD),
kidney transplant is a common adopted method to save the life of patients when
their renal function is seriously damaged. While, is the kidney transplant an
ideal method for patients? Is there any limit of it?
At present, kidney transplant is a common used treatment method for the
uremia. It is a modern high-technology method, which transplant a healthy kidney
into the patient’s body to replace the damaged kidney to maintain the normal
metabolism of the human body. However, during the operation of kidney transplant
and after the operation, patients are faced a lot of problems, including the
following aspects:
1, it is hard to find out a matched kidney in a short time and the cost of
the operation is relatively high, which is beyond the ability of many
patients.
2, there may be various complications after the operation, such as
infections, cardiovascular complications, digestive system complications,
disorder of endocrine, and metabolism, the complications of blood system,
tumours, relapse of the kidney disease, etc.
3, the long-term survival rate is low. After the kidney transplant operation,
the survival rate of one year is 90%, while the survival rate of five years is
5% and the survival rate of ten years is only 1%.
4, besides, the kidney transplant operation is not fit for many patients. For
example, patients are accompanied with the following disease should not adopt
kidney transplant: schizophrenia, metastatic tumors, chronic active hepatitis,
disseminated tuberculosis, stubborn heart failure, blood coagulation mechanism
deficit disorder, polyarteritis nodosa, coccidioidomycosis, acquired
immunodeficiency syndrome and primary oxalic acid salt urine disease.
5, after the operation, it is hard to avoid the rejection. This is because
that there is still alloantigen in the transplanted kidney. At present, as for
the various rejections, patients have to take many medicines to control them,
and at most cases, the medicine-taking lasts the whole life.